When you come to the Institute for head and neck cancer treatment, you can expect:
- A complete treatment plan that considers all aspects of your health and well-being
- A team of experts who collaborate on your treatment and work together to support you throughout the cancer journey
- The latest diagnostic technology and treatment options available all under one roof
While smoking does increase your risk for head and neck cancer, infection with the human papillomavirus (HPV) is the most common risk factor for these cancers. Fortunately, patients with head and neck cancer who are HPV-positive often have a good outcome.
No. Head and neck cancer treatment can come with some challenging side effects, such as dry mouth, swallowing problems or mouth sores (mucositis). However, most of these side effects resolve four to six weeks after treatment. The Institute also provides support services to help you cope with these side effects.
The Radixact™ TomoTherapy is an image-guided radiation therapy (IGRT) that combines 3D imaging with highly targeted radiation beams. The beams are delivered from 360 degrees around your body, which helps provide more precise radiation treatment.
At Lynn Cancer Institute, we treat cancer in today’s patients and offer hope for those who may get the disease in the future. Through clinical trials, we study promising new ways to diagnose and treat cancer. As our patient, you have access to these trials and treatments that aren’t widely available elsewhere. If a clinical trial may be right for you, we’ll talk with you about the potential benefits and risks. We make your overall well-being and safety our top priority if you choose to participate.